PLEGRIDY® (Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support Long-Term Safety and Efficacy in Multiple Sclerosis Patients
Go back to PLEGRIDY® (Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support Long-Term Safety and Efficacy in Multiple Sclerosis Patients| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 210.73 -1.77 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $212.50 | 52 Week High | $333.65 | |||
| Open | $210.50 | 52 Week Low | $223.02 | |||
| Day High | $213.48 | P/E | 26.98 | |||
| Day Low | $209.00 | EPS | $7.81 | |||
| Volume | 694,580 | |||||
